IBD-PSC research library
2,842 studies on inflammatory bowel disease with primary sclerosing cholangitis — surveillance, cancer risk, the colitis phenotype, the liver, and surgery. Curated from PubMed via an SR/MA-grade MeSH search.
Most recent
Comments on 'Cardiovascular risk profiles in patients with primary sclerosing cholangitis'Ansar S, Bhawish R · Eur J Gastroenterol Hepatol · 2026 · PMID 42832288
Oral Vancomycin Therapy for Primary Sclerosing Cholangitis: Beacon of Hope or a Dead End?Deneau M · Am J Gastroenterol · 2026 · PMID 42861527
Phenotype and prognosis of primary sclerosing cholangitis-autoimmune hepatitis variant syndromeKolev M, Bütikofer R, Krucker Y et al. · Dig Liver Dis · 2026 · PMID 42855375
Notation System for Liver Transplant Recipients: Key Information in Transplant ProcedureKojima H, Ito T, Yamane K et al. · J Hepatobiliary Pancreat Sci · 2026 · PMID 42850878
Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammationJördens MS, Nordhus KS, Øgaard J et al. · J Hepatol · 2026 · PMID 42833310
The Gut-Liver Immune Axis in Celiac Disease, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Outcomes of a Rare but Significant TriadPatwardhan SN, Yazdani O, Esbati R et al. · Res Sq · 2026 · PMID 42856450
Advances in primary sclerosing cholangitis careQu Z, Schmelzle M · Lancet · 2026 · PMID 42822470
Advances in primary sclerosing cholangitis care - Authors' replyBergquist A, von Seth E, Karlsen TH et al. · Lancet · 2026 · PMID 42822469
Advances in primary sclerosing cholangitis careJohnson KM, Kellermayer R, Buness CW et al. · Lancet · 2026 · PMID 42822468
Regulatory T cells in autoimmune liver diseasesChen S, Zhang H, Huang H et al. · Gut · 2026 · PMID 42823333
The Childhood Liver Disease Research Network's prospective characterization of pediatric primary sclerosing cholangitisMack CL, Miethke AG, Hawthorne K et al. · Hepatol Commun · 2026 · PMID 42758866
MELD exception in primary sclerosing cholangitis: A policy in search of evidenceHakim A, Bonder A · Liver Transpl · 2026 · PMID 42228715
Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations in inflammatory bowel disease: a population-based study in chinaXu Y, Wu K, Liu P et al. · Eur J Gastroenterol Hepatol · 2026 · PMID 42065992
Correction: Salvage tacrolimus therapy for steroid-refractory immune-related adverse event-associated sclerosing cholangitisIkeda S, Kawaguchi S, Baba K et al. · Clin J Gastroenterol · 2026 · PMID 42604916
Rapid Multisystem Improvement Following Upadacitinib in a PsAPASH-Like Overlap Phenotype With Concomitant Crohn's Disease and Primary Sclerosing CholangitisRosi E, Silvi G, Di Cesare A et al. · J Dermatol · 2026 · PMID 42572233
Cholecystectomy before diagnosis of primary sclerosing cholangitis is associated with markedly worsened transplant-free survivalFärkkilä MA, Arola JT, Tenca A et al. · JHEP Rep · 2026 · PMID 42508616
Short, not skinny: The distinct sarcopenia phenotype of pediatric primary sclerosing cholangitis-inflammatory bowel diseaseDahlwi G, Yodoshi T, O'Donnell JEM et al. · J Pediatr Gastroenterol Nutr · 2026 · PMID 42415658
Longitudinal GGT trajectories identify prognostic phenotypes in paediatric primary sclerosing cholangitisDenier D, Peng YE, Amin M et al. · JHEP Rep · 2026 · PMID 42362151
Aberrant p53 overexpression in benign colon biopsies may predict dysplasia risk in patients with primary sclerosing cholangitis and inflammatory bowel diseaseLouie JD, Lauwers GY, Choi WT · Histopathology · 2026 · PMID 42318959
Interferon-gamma-inducible protein-10 is associated to increased primary bile acids and fibrosis in primary sclerosing cholangitisLanghans B, Dold L, Zhou T et al. · J Steroid Biochem Mol Biol · 2026 · PMID 42303059